Edmund Harrigan, Director at Karuna Therapeutics, Inc. (KRTX), sold 10,000 shares at $93.40 ($934K) on 2020-07-13, disclosed to the SEC on 2020-07-13.
Open-market sale of $934k KRTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| KRTX | SELL | 2020-06-15 | $2.8M | — | Filing → |
| ACAD | BUY | 2016-08-18 | $33K | — | Filing → |